Evidence visual
GHK-Cu evidence and risk matrix
beginner researcher fit
Evidence
Tier B-C
Risk
med high
Regulatory
not approved
WADA
none
FDA
none
Route
topical
Mixed evidence profile. Useful for comparison, not a standalone protocol decision.
Overview
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) influences extracellular matrix remodeling (collagen/elastin/GAG synthesis) and modulates MMP/TIMP balance in fibroblast studies. Widely discussed in skin repair contexts with substantial topical/cosmetic literature. Injection 'peptide protocols' are not the evidence base. Generally better tolerated topically than systemic hormone peptides. Topical formats are usually easier to compare and evaluate than more aggressive research-use presentations.
Decision path
Where GHK-Cu fits in the research path.
Use the evidence and risk profile first, then compare vendors and run the quiz before turning this compound into a protocol decision.
01
Read evidence
02
Check risk
03
Compare options
04
Build plan
Peptide research path
Decide whether GHK-Cu belongs in your plan.
Use the quiz before choosing a compound, vendor, or PDF. It routes by goal, experience, budget, safety flags, and monitoring comfort.
Research Details
Influences extracellular matrix remodeling (collagen/elastin/GAG synthesis); modulates MMP/TIMP balance.
topical
Substantial topical/cosmetic literature. Injection protocols are not the evidence base.
Skin repair, collagen stimulation, wound healing support (topical evidence).
Skin remodeling: weeks to months (collagen turnover cycles).
Copper sensitivity.
Generally better tolerated topically than systemic peptides.
Unknown clinically; avoid stacking claims.
Cost at a glance
Typical cycle cost
$60.00
Estimated monthly
$60.00
Protocol style
Continuous / ongoing
Continuous
Estimate confidence
High confidence
Assumes roughly 40 mg–80 mg per cycle, using 2 tracked affiliated listings.
Topical skin use is closer to ongoing monthly use than a fixed cycle.
Age, sex, and monitoring
Life-stage fit
Broad adult fit for cosmetic and skin-repair goals, especially when route is topical rather than systemic.
Best fit age ranges: 35-44, 45-54, 55-64
Information provided for educational and research reference only. Not medical advice. Not for diagnosing, treating, curing, or preventing disease. Products referenced are labeled Research Use Only (RUO) by vendors; not for human or veterinary use.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Personalized peptide routing
Find the right path for GHK-Cu.
Take the quiz before choosing a compound, vendor, or PDF. We match your goal, experience, budget, and monitoring comfort to the next best step in the funnel.
- Goal-matched compound and protocol recommendations.
- Budget and sourcing filters before you leave the site.
- PDF unlocks shown after your personalized result.